Episodes featuring TBPN
Browse episodes where TBPN appears as host or guest. View all episodes →
TBPN hosts debate peptide safety and legitimacy with Martin Shkreli, who argues unregulated use is dangerous, while Superpower founder Max Polyakov defends BPC-157 based on real-world clinical experience.
TBPN breaks down Elon Musk's idea for an electromagnetic launcher on the moon, examining how it would work, how long it might take, and whether the economics make sense.
TBPN hosts cover Jeff Bezos's $100 billion AI manufacturing fund, an Nvidia chip smuggling scandal involving $2.5 billion in diverted servers, and luxury real estate.
TBPN covers Jeff Bezos's $100 billion AI manufacturing fund, the Super Micro Computer GPU smuggling scandal, and shifts in how elite engineers are compensated as AI costs rise.
TBPN hosts break down Jeff Bezos' reported $100 billion AI manufacturing fund, covering likely targets, valuations, and why Bezos may be well suited to fix low-margin U.S. factories.
TBPN covers Samsung's $70 billion chip manufacturing bet, Apple's AI app store revenue strategy, and Jeff Bezos' reported $100 billion manufacturing fund.
Mark Cuban joins TBPN to share his views on AI, humanoid robots, self-driving cars, and how students and entrepreneurs should position themselves for the next wave of tech.
Carl Eschenbach returns to Sequoia Capital as a partner and joins TBPN to discuss AI disruption, venture opportunities in 2026, and big moves in semiconductors and software.
TBPN covers Nvidia resuming chip sales to China, Apple cracking down on vibe coding apps, and a critique of Silicon Valley's peptide craze.
TBPN hosts argue that selling Nvidia H200 chips to China is strategically smarter than a ban, weighing economic ties against invasion risk and supply chain stability.
TBPN hosts break down OpenAI narrowing its focus to enterprise and coding, while covering Kalshi's $1B bracket challenge, Nvidia's DLSS5, and the SF housing market.
TBPN covers OpenAI pulling back from side projects to focus on enterprise, the threat AI poses to software private equity, and Meta's acquisition of Manus.
TBPN breaks down OpenAI's decision to cut side projects and double down on coding, enterprise, and compute scaling to stay competitive.
TBPN hosts discuss how AI is opening up biomedical research, using a story about an entrepreneur who used ChatGPT to help design a cancer vaccine for his dog.
Kevin Espiritu explains how he built Epic Gardening from a solo blog into a multi-million dollar business through e-commerce, a seed company acquisition, and his YouTube audience.
TBPN covers AI in biotech, the case for working harder during the AI transition, overheated private equity markets, and what is actually limiting AI scaling right now.
TBPN covers tall poppy syndrome and its effect on startup culture, ByteDance acquiring Blackwell chips despite export restrictions, and luxury home aquarium trends.
Travis Kalanick joins to unveil Adams, a venture combining automated food production, real estate infrastructure, and robotics, after 8 years of building in stealth.
Uber founder Travis Kalanick joins TBPN as his company, in stealth for eight years, emerges as Atoms. It adds mining and wheeled robot transport to its food business, and he shares lessons on fundraising, moats and...
Palantir CEO Alex Karp talks with TBPN about how AI will eliminate white-collar jobs, why society is unprepared for it, and what the US must do to stay ahead of China.